Ocugen (NASDAQ:OCGN) presented top-line 12-month results from its Phase II ArMaDa clinical trial evaluating OCU410, a ...
This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory ...
The Telangana government is exploring a pod-based transport system to improve last-mile connectivity for commuters using the ...
In the NFL’s player ecosystem, the margin between a Super Bowl run and a top-five draft pick is often thinner than a single ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...
Researchers will join a new NIH-supported network working to develop novel approach methodologies that complement or replace ...
A new rehab gym for people with neurological injuries or conditions just opened in Tulsa. It offers activity-based therapy, ...
The Aviationist on MSN
The Tomcat's Six Pack: The F-14 Six on Six Phoenix Test
Designed for fleet air defense, the F-14 was armed with a potent long-range missile and, with a powerful new radar, could ...
Danny Scudero is arguably Colorado's top transfer addition, and one outlet believes he could elevate the Buffs' passing ...
A research team at NYU Langone Health and Sage Bionetworks has been awarded a $25 million grant to establish the ...
Speaking at the Sportstar Focus Bihar Conclave in Patna, the badminton great proposed an education pathway that can blend ...
Awhad said that a major overhaul of existing routes is underway, with a clear shift in strategy to complement the city’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results